FDA discourages people against 'young blood' infusions, which make unproven claims to reverse aging

The FDA is advising against 'young blood' infusions, in which people are infused with plasma from young donors. It warns consumers that clinics are making unproven claims that the treatment can reverse aging.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Vows To Strengthen Oversight Of Multibillion-Dollar Dietary Supplement IndustryFDA vows to strengthen oversight of multibillion-dollar dietary supplement industry
Read more »

Ketamine-like depression treatment on track for FDA approvalA ketamine-like drug for treatment-resistant depression was backed by a US Food and Drug Administration advisory committee on Tuesday. If it is then approved by the FDA, the drug -- called esketamine -- may provide a new option for patients with major depressive disorder who have tried at least two other antidepressants without success.
Read more »